Synthesis and evaluation of heterocycle structures as potential inhibitors of Mycobacterium tuberculosis UGM

Bioorganic & Medicinal Chemistry
2020.0

Abstract

In this study, we screen three heterocyclic structures as potential inhibitors of UDP-galactopyranose mutase (UGM), an enzyme involved in the biosynthesis of the cell wall of Mycobacterium tuberculosis. In order to understand the binding mode, docking simulations are performed on the best inhibitors. Their activity on Mycobacterium tuberculosis is also evaluated. This study made it possible to highlight an "oxazepino-indole" structure as a new inhibitor of UGM and of M. tuberculosis growth in vitro.

Knowledge Graph

Similar Paper

Synthesis and evaluation of heterocycle structures as potential inhibitors of Mycobacterium tuberculosis UGM
Bioorganic & Medicinal Chemistry 2020.0
Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacement
Bioorganic & Medicinal Chemistry 2022.0
Synthesis and Evaluation of Nitrofuranylamides as Novel Antituberculosis Agents
Journal of Medicinal Chemistry 2004.0
Identification of a new and diverse set of Mycobacterium tuberculosis uracil-DNA glycosylase (MtUng) inhibitors using structure-based virtual screening: Experimental validation and molecular dynamics studies
Bioorganic & Medicinal Chemistry Letters 2022.0
Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study
Bioorganic & Medicinal Chemistry 2015.0
Discovery of the first Mycobacterium tuberculosis MabA (FabG1) inhibitors through a fragment-based screening
European Journal of Medicinal Chemistry 2020.0
Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties
European Journal of Medicinal Chemistry 2011.0
Synthetic Sansanmycin Analogues as Potent Mycobacterium tuberculosis Translocase I Inhibitors
Journal of Medicinal Chemistry 2021.0
Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors
Bioorganic & Medicinal Chemistry 2014.0
Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis
European Journal of Medicinal Chemistry 2016.0